Stago's 2025 CSR Report is online
The Stago Group’s commitment to sustainability takes a new step forward with the release of our latest CSR report. More comprehensive, concrete, and forward-looking, it reflects the collective efforts of our international teams and subsidiaries, and the growing integration of CSR into our daily actions and long-term vision.
Read more
New Practical Manual on Hemostasis and Thrombosis in special patient populations
This new book is dedicated to the challenges of hemostasis and thrombosis in special patient populations, offering practical guidance for interpreting test results and improving patient care.
Read more
Stago at the 33rd Annual Congress of the ISTH in Washington, DC
The 33rd Annual Congress of the ISTH (International Society on Thrombosis and Hemostasis) was held in Washington, DC, bringing together thousands of hemostasis specialists from around the world.
Read more
QUALIblood: Our new partner in advancing the diagnosis of thrombosis risk
On 14 February 2025, QUALIblood and Diagnostica Stago formalised a strategic alliance focused on the development and future launch of a new reagent kit, nAPCsr – a thrombin generation test designed to assess thrombosis risk in women considering or currently using oestrogen-based hormonal treatments, particularly oral contraceptives.
Read more
A new look for Stago's scientific posters
Sharing and deepening knowledge is essential if we are to become a benchmark in the field of blood diagnostics. With this in mind, six scientific posters have been updated and redesigned to offer more up-to-date and accurate content.
Read more
